# A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection

> **NCT02205307** · NA · TERMINATED · sponsor: **Novadaq Technologies ULC, now a part of Stryker** · enrollment: 347 (actual)

## Conditions studied

- Rectal Cancer
- Rectosigmoid Cancer

## Interventions

- **DEVICE:** PINPOINT
- **DEVICE:** SPY Elite

## Key facts

- **NCT ID:** NCT02205307
- **Lead sponsor:** Novadaq Technologies ULC, now a part of Stryker
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 347 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2020-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02205307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02205307, "A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02205307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*